This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Albert-Ludwigs-Universitaet Freiburg. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Gregory Stevens: Innovator in Botulinum Toxin Detection
Introduction
Gregory Stevens is a notable inventor based in Freiburg, Germany. He has made significant contributions to the field of biotechnology, particularly in the detection of harmful substances. His work focuses on developing innovative methods for identifying the presence of Botulinum toxin, a potent neurotoxin.
Latest Patents
One of Gregory Stevens' key inventions is an assay for Clostridium botulinum neurotoxin. This patent relates to materials and methods suitable for determining the presence or amount of Botulinum toxin (BoNT) in a test sample. The assay utilizes a luminescence method, where the substrate peptide is specifically designed for accurate detection.
Career Highlights
Throughout his career, Gregory has worked at prestigious institutions, including Albert-Ludwigs-Universität Freiburg. His research has contributed to advancements in the field of toxin detection, enhancing safety measures in various applications.
Collaborations
Gregory has collaborated with several professionals in his field, including Michael Krueger and Andrea Zgaga-Griesz. These partnerships have fostered a collaborative environment that promotes innovation and research excellence.
Conclusion
Gregory Stevens is a distinguished inventor whose work in Botulinum toxin detection has made a significant impact in biotechnology. His innovative approaches continue to advance the field and contribute to public safety.